ARTICLE | Clinical News
Transgene starts cervical cancer Phase II
October 18, 2001 7:00 AM UTC
Transgene (NM:Transgene; TRGNY) began in Mexico a 57-patient Phase II trial to test the efficacy of multiple subcutaneous injections of its MVA-HPV-IL2 immunotherapeutic in female cervical cancer pati...